Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia.
Authors: Downen SS; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville., Farag HM; Pharmaceutical Sciences Department, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.; Department of Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston., Davies A; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia., Okeke CM; Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, Texas., Ben-Umeh KC; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City., Yunusa I; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia.; Center for Outcomes Research and Evaluation, University of South Carolina College of Pharmacy, Columbia., Eguale T; Department of Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston.
Source: JAMA network open [JAMA Netw Open] 2026 Feb 02; Vol. 9 (2), pp. e2557536. Date of Electronic Publication: 2026 Feb 02.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first